Enliven Therapeutics Gains FDA Approval for ENABLE-2 Trial of Relcobatinib in CML Patients #United_States #Burlingame #Enliven_Therapeutics #relcobatinib #chronic_myeloid_leukemia
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialEnliven Therapeutics Gains FDA Approval for ENABLE-2 Trial of Relcobatinib in CML Patients #United_States #Burlingame #Enliven_Therapeutics #relcobatinib #chronic_myeloid_leukemia